Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8+lymphocytes
Author:
Affiliation:
1. pharmazentrum frankfurt/ZAFES; Hospital of the Goethe University; Frankfurt am Main Germany
2. Center for Neurology and Neurosurgery; Hospital of the Goethe University; Frankfurt am Main Germany
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201545805/fullpdf
Reference52 articles.
1. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis;Brinkmann;Nat. Rev. Drug Discov,2010
2. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen;Schröder;Mol. Immunol.,2011
3. Sphingosine 1-phosphate modulates antigen capture by murine langerhans cells via the S1P2 receptor subtype;Japtok;PLoS One,2012
4. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2;Paugh;FEBS Lett,2003
5. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720;Hisano;J. Biol. Chem.,2011
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fingolimod (FTY720) Hinders Interferon-γ-Mediated Fibrotic Scar Formation and Facilitates Neurological Recovery After Spinal Cord Injury;Journal of Neurotrauma;2023-12-01
2. Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor;Journal of Immunology Research;2023-04-07
3. Targeting Sphingolipids for Cancer Therapy;Frontiers in Oncology;2021-10-19
4. Cytokines and Transgenic Matrix in Autoimmune Diseases: Similarities and Differences;Biomedicines;2020-12-01
5. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease;Advances in Protein Chemistry and Structural Biology;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3